Personalis Named to Inc.'s 2021 Best-Led Companies List

About this update from Personalis, Inc.

[{"type":"text","content":"\nPersonalis recognized in inaugural roundup for proven track record of management excellence\n\n MENLO PARK, Calif.--(BUSINESS WIRE)--\nPersonalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced that it has been named to Inc.’s inaugural 2021 Best-Led Companies list — a select, data-driven list of U.S.-based companies with the strongest management excellence and revenue of $50 million to $2 billion. Personalis was recognized for its accomplishments in four key areas including: performance and value creation; market penetration and customer engagement; talent; and leadership team.\n\n“This inaugural list of companies represents the remarkable midsized companies, both public and private, often founder led, that are at the vanguard of reinventing American business,” said Scott Omelianuk, editor-in-chief of Inc. magazine. “With their leadership, all business will benefit from an exciting, competitive future full of possibilities.”\n\n“We are honored to be named to the first Best-Led Companies List,” said John West, Personalis’ Chief Executive Officer. “I am proud of what the company has achieved during these challenging times. We have grown the company, increased revenue every quarter and continued to deliver new, industry-leading products to the market”.\n\nThe list recognizes 250 companies that are agile enough to maneuver but also big enough to have a broad impact. These companies employ 35 million people, about one of four U.S. workers. All 250 have a successful track record with leadership teams that spur solid performance, create value, penetrate markets, engage with customers, and more.\n\nTo compile the list, Inc. evaluated private and public U.S.-based companies using a proprietary 14-point measure of management excellence generated with input from partners at Pitchbook and Shango Labs.\n\nTo see the complete list, visit https://www.inc.com/best-led-companies/2021. The November issue of Inc. magazine is available online now at https://www.inc.com/magazine.\n\nAbout Personalis\n\nPersonalis, Inc. is a leader in advanced cancer genomics for enabling the next generation of precision cancer therapies and diagnostics. The Personalis NeXT Platform® is designed to adapt to the complex and evolving understanding of cancer, providing its biopharmaceutical customers and clinicians with information on ...

More updates from Personalis, Inc.